OR WAIT null SECS
© 2022 MJH Life Sciences™ and Formulary Watch. All rights reserved.
The injectable antibiotic ertapenem (Invanz, Merck) was approved by FDA to treat moderate-to-severe complicated foot infections due to indicated pathogens in patients who have diabetes without osteomyelitis